Prime Medicine (PRME) Change in Receivables (2024 - 2025)
Prime Medicine (PRME) posted Change in Receivables of -$120000.0 for Q3 2025, down 216.5% on a QoQ basis from $103000.0 in Q2 2025, and down 100.22% year-over-year from $55.0 million in Q3 2024.
Prime Medicine (PRME) Change in Receivables (2024 - 2025) Analysis & Trends
Prime Medicine's Change in Receivables history runs 2 years deep, the most recent figure standing at -$120000.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Prime Medicine | 524.20 Mn | 524.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -120,000.00 |
| Sep 30, 2025 | -120,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Sep 30, 2024 | 55.00 Mn |
| Sep 30, 2024 | 55.00 Mn |